FHIT Gene and Cervical Cancer
Author Information
Author(s): Nakagawa S, Yoshikawa H, Kimura M, Kawana K, Matsumoto K, Onda T, Kino N, Yamada M, Yasugi T, Taketani Y
Primary Institution: Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo
Hypothesis
Is there an involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix?
Conclusion
The aberrant expression of the FHIT gene is found in precursor lesions of cervical carcinoma and invasive carcinomas, but its incidence does not increase with the advancement of clinical stage.
Supporting Evidence
- The study detected aberrant FHIT transcripts in 44% of cervical invasive squamous cell carcinomas.
- The aberrant expression was found in 36% of high-grade cervical intraepithelial neoplasias.
- No aberrant FHIT expression was found in low-grade CINs or non-squamous types.
Takeaway
The study found that a gene called FHIT is expressed differently in cervical cancer and its early forms, which might be important for understanding how this type of cancer develops.
Methodology
The study examined FHIT gene expression using RT-PCR and cDNA sequencing in cervical invasive carcinomas and precursor lesions.
Participant Demographics
32 cervical invasive carcinomas (25 squamous cell carcinomas and 7 adeno- or adenosquamous carcinomas) and 18 precursor lesions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website